Applicability of EU(7)-PIM criteria in cross-national studies in European countries.
Daniela FialovaJovana BrkićBlanca LaffonJindra ReissigováSilvia GrešákováSoner DoganPeter DoroLjiljana TasićValentina MarinkovićVanessa ValdiglesiasSolange CostaJan KostřibaPublished in: Therapeutic advances in drug safety (2019)
The EU(7)-PIM list was created for utilization in European studies; however, applicability of this list is still limited in some countries, particularly in Eastern and Central Europe. The EU project EUROAGEISM H2020 (2017-2021) that focuses on PIM prescribing and regulatory measures in Central and Eastern European countries must consider these limits.